Surface-enhanced Raman spectroscopy before radical prostatectomy predicts biochemical recurrence better than CAPRA-S

References

• SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
   PubMed Web of Science ®Google Scholar
• NovaraGFicarraVMocellinSSystematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomyEur Urol201262338240422749851
   PubMed Web of Science ®Google Scholar
• FreedlandSJHumphreysEBMangoldLARisk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomyJAMA2005294443343916046649
   PubMed Web of Science ®Google Scholar
• FossatiNKarnesRJCozzariniCAssessing the optimal timing for early salvage radiation therapy in patients with prostate-specific antigen rise after radical prostatectomyEur Urol201669472873326497924
   PubMedGoogle Scholar
• AbugharibAJacksonWCTumatiVVery early salvage radiotherapy improves distant metastasis-free survivalJ Urol2017197366266827614333
   PubMedGoogle Scholar
• MessingEMManolaJYaoJImmediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomyLancet Oncol20067647247916750497
   PubMed Web of Science ®Google Scholar
• TilkiDMandelPSchlommTExternal validation of the CAPRA-S score to predict biochemical recurrence, metastasis and mortality after radical prostatectomy in a European cohortJ Urol201519361970197525498570
   PubMed Web of Science ®Google Scholar
• PunnenSFreedlandSJPrestiJCMulti-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomyEur Urol20146561171117723587869
   PubMed Web of Science ®Google Scholar
• WalzJChunFKKleinEANomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancerJ Urol2009181260160819084864
   PubMedGoogle Scholar
• HansenJBianchiMSunMPercentage of high-grade tumour volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared with Gleason scoreBJU Int2014113339940724053339
   PubMedGoogle Scholar
• KellyRSVander HeidenMGGiovannucciEMucciLAMetabolomic biomarkers of prostate cancer: prediction, diagnosis, progression, prognosis, and recurrenceCancer Epidemiol Biomarkers Prev201625688790627197278
   PubMed Web of Science ®Google Scholar
• MaxeinerAAdkinsCBZhangYRetrospective analysis of prostate cancer recurrence potential with tissue metabolomic profilesProstate201070771071720017167
   PubMedGoogle Scholar
• McdunnJELiZAdamKPMetabolomic signatures of aggressive prostate cancerProstate201373141547156023824564
   PubMed Web of Science ®Google Scholar
• StablerSKoyamaTZhaoZSerum methionine metabolites are risk factors for metastatic prostate cancer progressionPLoS One201168e2248621853037
   PubMedGoogle Scholar
• LaneLAQianXNieSSERS nanoparticles in medicine: from label-free detection to spectroscopic taggingChem Rev201511519104891052926313254
   PubMedGoogle Scholar
• BastúsNGComengeJPuntesVPuntesVKinetically controlled seeded growth synthesis of citrate-stabilized gold nanoparticles of up to 200 nm: size focusing versus Ostwald ripeningLangmuir20112717110981110521728302
   PubMedGoogle Scholar
• JermynMDesrochesJAubertinKA review of Raman spectroscopy advances with an emphasis on clinical translation challenges in oncologyPhys Med Biol20166123R370R40027804917
   PubMed Web of Science ®Google Scholar
• AubertinKTrinhVQJermynMMesoscopic characterization of prostate cancer using Raman spectroscopy: potential for diagnostics and therapeuticsBJU Int2018122232633629542855
   PubMedGoogle Scholar
• SchlückerSSurface-enhanced Raman spectroscopy: concepts and chemical applicationsAngew Chem Int Ed Engl201453194756479524711218
   PubMed Web of Science ®Google Scholar
• FengSChenRLinJNasopharyngeal cancer detection based on blood plasma surface-enhanced Raman spectroscopy and multivariate analysisBiosens Bioelectron201025112414241920427174
   PubMed Web of Science ®Google Scholar
• FengSChenRLinJGastric cancer detection based on blood plasma surface-enhanced Raman spectroscopy excited by polarized laser lightBiosens Bioelectron20112673167317421227679
   PubMed Web of Science ®Google Scholar
• FengSLinDLinJBlood plasma surface-enhanced Raman spectroscopy for non-invasive optical detection of cervical cancerAnalyst2013138143967397423529624
   PubMed Web of Science ®Google Scholar
• XiaoRZhangXRongZNon-invasive detection of hepatocellular carcinoma serum metabolic profile through surface-enhanced Raman spectroscopyNanomedicine20161282475248427520725
   PubMedGoogle Scholar
• ShaoXPanJWangYEvaluation of expressed prostatic secretion and serum using surface-enhanced Raman spectroscopy for the noninvasive detection of prostate cancer, a preliminary studyNanomedicine20171331051105927979746
   PubMed Web of Science ®Google Scholar
• FengJGangFLiXPlasma cell-free DNA and its DNA integrity as biomarker to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate-specific antigenInt Urol Nephrol20134541023102823779229
   PubMed Web of Science ®Google Scholar
• YinCLuoCHuWDingXYuanCWangFQuantitative and qualitative analysis of circulating cell-free dna can be used as an adjuvant tool for prostate cancer screening: a meta-analysisDisease Markers201620164112
   Google Scholar
• BastianPJPalapattuGSYegnasubramanianSPrognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomyClin Cancer Res20071318 Pt 15361536717875764
   PubMed Web of Science ®Google Scholar
• WroclawskiMLSerpa-NetoAFonsecaFLCell-free plasma DNA as biochemical biomarker for the diagnosis and follow-up of prostate cancer patientsTumour Biol20133452921292723715778
   PubMed Web of Science ®Google Scholar
• Di MeoABartlettJChengYPasicMDYousefGMLiquid biopsy: a step forward towards precision medicine in urologic malignanciesMol Cancer20171618028410618
   PubMed Web of Science ®Google Scholar
• WuXDanielsGLeePMonacoMELipid metabolism in prostate cancerAm J Clin Exp Urol20142211112025374912
   PubMedGoogle Scholar